Pfizer says not facing production issues with Covid-19 vaccine | Malay Mail
WASHINGTON, Dec 18 — Pfizer Inc said yesterday it was not facing any production issues with its Covid-19 vaccine, a day after US officials pointed to challenges with the company’s manufacturing. The company said it was confident in its ability to deliver up to 50 million doses globally this...
Friday, 18 Dec 2020 08:50 AM MYTPfizer Inc said yesterday it was not facing any production issues with its Covid-19 vaccine. — AFP picWASHINGTON, Dec 18 — Pfizer Inc said yesterday it was not facing any production issues with its Covid-19 vaccine, a day after US officials pointed to challenges with the company’s manufacturing.
The company said it was confident in its ability to deliver up to 50 million doses globally this year and up to 1.3 billion next year.“No shipments containing the vaccine are on hold or delayed. This week, we successfully shipped all 2.9 million doses that we were asked to ship by the US Government to the locations specified by them,” Pfizer said in a statement.
The US government has signed a deal with Pfizer for a 100 million doses of the vaccine, which has started being rolled out across the country under an emergency use authorization.Pfizer had reported some production issues with the vaccine, US Secretary of Health and Human Services Alex Azar said on Wednesday. He had said the US government would provide the company full support to ensure it can produce the vaccine for American people. — Reuters headtopics.com
Read more: Malay Mail »Covid-19: Transition to endemic phase to be announced within two to three weeks, says Hisham
KUALA LUMPUR: The transition from the pandemic to endemic phase of Covid-19 in Malaysia might be announced within the next two to three weeks, says Datuk Seri Hishammuddin Hussein.